Pitfalls in the evaluation of melanocytic lesions

Histopathology

Volumn 60, Issue 5, 2012, Pages 690-705

  Brenn, Thomas ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Halo; Melanoma; Nevus; Nevus blue; Pigmented

Indexed keywords

HISTONE H3; MELAN A; MELANIN; PROTEIN S 100;

BLUE NEVUS; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL MATURATION; CLEAR CELL SARCOMA; CONGENITAL NEVUS; CRYOTHERAPY; CYTOKINE PRODUCTION; CYTOLOGY; DENDRITIC CELL; DIAGNOSTIC ERROR; DIFFERENTIAL DIAGNOSIS; FLUORESCENCE IN SITU HYBRIDIZATION; GROUPS BY AGE; HALO NEVUS; HISTIOCYTE; HISTOLOGY; HISTOPATHOLOGY; HUMAN; HYALINE DEGENERATION; IMMUNOHISTOCHEMISTRY; JUVENILE MELANOMA; LICHENOID; LOW LEVEL LASER THERAPY; MAST CELL; MELANOCYTE; MELANOMA; MELANOSIS; MITOSIS; MYXOMA; NEURILEMOMA; PIGMENTATION; PREGNANCY; PREGNANCY DISORDER; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECURRENT CANCER; REVIEW; VISCERAL METASTASIS;

DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC ERRORS; HUMANS; MELANOMA; NEVUS; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84859003024     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2011.04042.x     Document Type: Review

References (80)

1. Musette P, Bachelez H, Flageul B et al. Immune-mediated destruction of melanocytes in halo nevi is associated with the local expansion of a limited number of T cell clones. J. Immunol. 1999; 162; 1789-1794.
2. Zeff RA, Freitag A, Grin CM, Grant-Kels JM. The immune response in halo nevi. J. Am. Acad. Dermatol. 1997; 37; 620-624.
3. Moretti S, Spallanzani A, Pinzi C, Prignano F, Fabbri P. Fibrosis in regressing melanoma versus nonfibrosis in halo nevus upon melanocyte disappearance: could it be related to a different cytokine microenvironment? J. Cutan. Pathol. 2007; 34; 301-308.
4. Wayte DM, Helwig EB. Halo nevi. Cancer 1968; 22; 69-90.
5. Brazzelli V, Larizza D, Martinetti M et al. Halo nevus, rather than vitiligo, is a typical dermatologic finding of Turner's syndrome: clinical, genetic, and immunogenetic study in 72 patients. J. Am. Acad. Dermatol. 2004; 51; 354-358.
6. Mooney MA, Barr RJ, Buxton MG. Halo nevus or halo phenomenon? A study of 142 cases J. Cutan. Pathol. 1995; 22; 342-348.
7. Langer K, Konrad K. Congenital melanocytic nevi with halo phenomenon: report of two cases and a review of the literature. J. Dermatol. Surg. Oncol. 1990; 16; 377-380.
8. Harvell JD, Meehan SA, LeBoit PE. Spitz's nevi with halo reaction: a histopathologic study of 17 cases. J. Cutan. Pathol. 1997; 24; 611-619.
9. Bergman W, Willemze R, de Graaff-Reitsma C, Ruiter DJ. Analysis of major histocompatibility antigens and the mononuclear cell infiltrate in halo nevi. J. Invest. Dermatol. 1985; 85; 25-29.
10. Denianke KS, Gottlieb GJ. Granulomatous inflammation in nevi undergoing regression (halo phenomenon): a report of 6 cases. Am. J. Dermatopathol. 2008; 30; 233-235.
11. Akasu R, From L, Kahn HJ. Characterization of the mononuclear infiltrate involved in regression of halo nevi. J. Cutan. Pathol. 1994; 21; 302-311.
12. Hoang MP, Prieto VG, Burchette JL, Shea CR. Recurrent melanocytic nevus: a histologic and immunohistochemical evaluation. J. Cutan. Pathol. 2001; 28; 400-406.
13. King R, Hayzen BA, Page RN, Googe PB, Zeagler D, Mihm MC Jr. Recurrent nevus phenomenon: a clinicopathologic study of 357 cases and histologic comparison with melanoma with regression. Mod. Pathol. 2009; 22; 611-617.
14. Kornberg R, Ackerman AB. Pseudomelanoma: recurrent melanocytic nevus following partial surgical removal. Arch. Dermatol. 1975; 111; 1588-1590.
15. Park HK, Leonard DD, Arrington JH III, Lund HZ. Recurrent melanocytic nevi: clinical and histologic review of 175 cases. J. Am. Acad. Dermatol. 1987; 17; 285-292.
16. Sexton M, Sexton CW. Recurrent pigmented melanocytic nevus. A benign lesion, not to be mistaken for malignant melanoma. Arch. Pathol. Lab. Med. 1991; 115; 122-126.
17. Sommer LL, Barcia SM, Clarke LE, Helm KF. Persistent melanocytic nevi: a review and analysis of 205 cases. J. Cutan. Pathol. 2011; 38; 503-507.
18. Chan MP, Chan MM, Tahan SR. Melanocytic nevi in pregnancy: histologic features and Ki-67 proliferation index. J. Cutan. Pathol. 2010; 37; 843-851.
19. Driscoll MS, Grant-Kels JM. Nevi and melanoma in pregnancy. Dermatol. Clin. 2006; 24; 199-204, vi.
20. Nading MA, Nanney LB, Boyd AS, Ellis DL. Estrogen receptor beta expression in nevi during pregnancy. Exp. Dermatol. 2008; 17; 489-497.
21. Pennoyer JW, Grin CM, Driscoll MS et al. Changes in size of melanocytic nevi during pregnancy. J. Am. Acad. Dermatol. 1997; 36; 378-382.
22. Zampino MR, Corazza M, Costantino D, Mollica G, Virgili A. Are melanocytic nevi influenced by pregnancy? A dermoscopic evaluation Dermatol. Surg. 2006; 32; 1497-1504.
23. Foucar E, Bentley TJ, Laube DW, Rosai J. A histopathologic evaluation of nevocellular nevi in pregnancy. Arch. Dermatol. 1985; 121; 350-354.
24. Sanchez JL, Figueroa LD, Rodriguez E. Behavior of melanocytic nevi during pregnancy. Am. J. Dermatopathol. 1984; 6(Suppl.); 89-91.
25. Grin CM, Rojas AI, Grant-Kels JM. Does pregnancy alter melanocytic nevi? J. Cutan. Pathol. 2001; 28; 389-392.
26. Glatz K, Hartmann C, Antic M, Kutzner H. Frequent mitotic activity in banal melanocytic nevi uncovered by immunohistochemical analysis. Am. J. Dermatopathol. 2010; 32; 643-649.
27. Jensen SL, Radfar A, Bhawan J. Mitoses in conventional melanocytic nevi. J. Cutan. Pathol. 2007; 34; 713-715.
28. Gottlieb GJ, Ackerman AB. Mitotic figures may be seen in cells of banal melanocytic nevi. Am. J. Dermatopathol. 1985; 7(Suppl.); 87-91.
29. Ruhoy SM, Kolker SE, Murry TC. Mitotic activity within dermal melanocytes of benign melanocytic nevi: a study of 100 cases with clinical follow-up. Am. J. Dermatopathol. 2011; 33; 167-172.
30. Zembowicz A, McCusker M, Chiarelli C et al. Morphological analysis of nevoid melanoma: a study of 20 cases with a review of the literature. Am. J. Dermatopathol. 2001; 23; 167-175.
31. Gerami P, Wass A, Mafee M, Fang Y, Pulitzer MP, Busam KJ. Fluorescence in situ hybridization for distinguishing nevoid melanomas from mitotically active nevi. Am. J. Surg. Pathol. 2009; 33; 1783-1788.
32. Barr RJ, Morales RV, Graham JH. Desmoplastic nevus: a distinct histologic variant of mixed spindle cell and epithelioid cell nevus. Cancer 1980; 46; 557-564.
33. Mackie RM, Doherty VR. The desmoplastic melanocytic naevus: a distinct histological entity. Histopathology 1992; 20; 207-211.
34. Sherrill AM, Crespo G, Prakash AV, Messina JL. Desmoplastic nevus: an entity distinct from spitz nevus and blue nevus. Am. J. Dermatopathol. 2011; 33; 35-39.
35. Kucher C, Zhang PJ, Pasha T et al. Expression of Melan-A and Ki-67 in desmoplastic melanoma and desmoplastic nevi. Am. J. Dermatopathol. 2004; 26; 452-457.
36. Harris GR, Shea CR, Horenstein MG, Reed JA, Burchette JL Jr, Prieto VG. Desmoplastic (sclerotic) nevus: an underrecognized entity that resembles dermatofibroma and desmoplastic melanoma. Am. J. Surg. Pathol. 1999; 23; 786-794.
37. Gerami P, Beilfuss B, Haghighat Z, Fang Y, Jhanwar S, Busam KJ. Fluorescence in situ hybridization as an ancillary method for the distinction of desmoplastic melanomas from sclerosing melanocytic nevi. J. Cutan. Pathol. 2011; 38; 329-334.
38. High WA, Alanen KW, Golitz LE. Is melanocytic nevus with focal atypical epithelioid components (clonal nevus) a superficial variant of deep penetrating nevus? J. Am. Acad. Dermatol. 2006; 55; 460-466.
39. Murali R, McCarthy SW, Thompson JF, Scolyer RA. Melanocytic nevus with focal atypical epithelioid components (clonal nevus) is a combined nevus. J. Am. Acad. Dermatol. 2007; 56; 889-890.
40. Robson A, Morley-Quante M, Hempel H, McKee PH, Calonje E. Deep penetrating naevus: clinicopathological study of 31 cases with further delineation of histological features allowing distinction from other pigmented benign melanocytic lesions and melanoma. Histopathology 2003; 43; 529-537.
41. Seab JA Jr, Graham JH, Helwig EB. Deep penetrating nevus. Am. J. Surg. Pathol. 1989; 13; 39-44.
42. Cooper PH. Deep penetrating (plexiform spindle cell) nevus. A frequent participant in combined nevus. J. Cutan. Pathol. 1992; 19; 172-180.
43. Skelton HG III, Smith KJ, Barrett TL, Lupton GP, Graham JH. HMB-45 staining in benign and malignant melanocytic lesions. A reflection of cellular activation. Am. J. Dermatopathol. 1991; 13; 543-550.
44. Zembowicz A, Carney JA, Mihm MC. Pigmented epithelioid melanocytoma: a low-grade melanocytic tumor with metastatic potential indistinguishable from animal-type melanoma and epithelioid blue nevus. Am. J. Surg. Pathol. 2004; 28; 31-40.
45. Zembowicz A, Knoepp SM, Bei T et al. Loss of expression of protein kinase a regulatory subunit 1alpha in pigmented epithelioid melanocytoma but not in melanoma or other melanocytic lesions. Am. J. Surg. Pathol. 2007; 31; 1764-1775.
46. Carney JA, Ferreiro JA. The epithelioid blue nevus. A multicentric familial tumor with important associations, including cardiac myxoma and psammomatous melanotic schwannoma. Am. J. Surg. Pathol. 1996; 20; 259-272.
47. Carney JA, Stratakis CA. Epithelioid blue nevus and psammomatous melanotic schwannoma: the unusual pigmented skin tumors of the Carney complex. Semin. Diagn. Pathol. 1998; 15; 216-224.
48. O'Grady TC, Barr RJ, Billman G, Cunningham BB. Epithelioid blue nevus occurring in children with no evidence of Carney complex. Am. J. Dermatopathol. 1999; 21; 483-486.
49. Groben PA, Harvell JD, White WL. Epithelioid blue nevus: neoplasm Sui generis or variation on a theme? Am. J. Dermatopathol. 2000; 22; 473-488.
50. Moreno C, Requena L, Kutzner H, de la Cruz A, Jaqueti G, Yus ES. Epithelioid blue nevus: a rare variant of blue nevus not always associated with the Carney complex. J. Cutan. Pathol. 2000; 27; 218-223.
51. Pinto A, Raghavendra S, Lee R, Derossi S, Alawi F. Epithelioid blue nevus of the oral mucosa: a rare histologic variant. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 2003; 96; 429-436.
52. Antony FC, Sanclemente G, Shaikh H, Trelles AS, Calonje E. Pigment synthesizing melanoma (so-called animal type melanoma): a clinicopathological study of 14 cases of a poorly known distinctive variant of melanoma. Histopathology 2006; 48; 754-762.
53. Crowson AN, Magro CM, Mihm MC Jr. Malignant melanoma with prominent pigment synthesis: 'animal type' melanoma - a clinical and histological study of six cases with a consideration of other melanocytic neoplasms with prominent pigment synthesis. Hum. Pathol. 1999; 30; 543-550.
54. Ludgate MW, Fullen DR, Lee J et al. Animal-type melanoma: a clinical and histopathological study of 22 cases from a single institution. Br. J. Dermatol. 2010; 162; 129-136.
55. Mandal RV, Murali R, Lundquist KF et al. Pigmented epithelioid melanocytoma: favorable outcome after 5-year follow-up. Am. J. Surg. Pathol. 2009; 33; 1778-1782.
56. Scolyer RA, Thompson JF, Warnke K, McCarthy SW. Pigmented epithelioid melanocytoma. Am. J. Surg. Pathol. 2004; 28; 1114-1115; author reply 1115-1116.
57. Ng SH, Chave TA. Tumoral melanosis as a manifestation of a completely regressed primary melanoma with metastases. Br. J. Dermatol. 2006; 155; 627-628.
58. Kossard S. A blue-black macule of recent onset (tumoral melanosis). Australas. J. Dermatol. 1996; 37; 215-217.
59. Flax SH, Skelton HG, Smith KJ, Lupton GP. Nodular melanosis due to epithelial neoplasms: a finding not restricted to regressed melanomas. Am. J. Dermatopathol. 1998; 20; 118-122.
60. Rodriguez HA, Ackerman LV. Cellular blue nevus. Clinicopathologic study of forty-five cases. Cancer 1968; 21; 393-405.
61. Temple-Camp CR, Saxe N, King H. Benign and malignant cellular blue nevus. A clinicopathological study of 30 cases. Am. J. Dermatopathol. 1988; 10; 289-296.
62. Zembowicz A, Granter SR, McKee PH, Mihm MC. Amelanotic cellular blue nevus: a hypopigmented variant of the cellular blue nevus: clinicopathologic analysis of 20 cases. Am. J. Surg. Pathol. 2002; 26; 1493-1500.
63. Cerroni L, Borroni RG, Massone C, Kerl H. 'Ancient' blue nevi (cellular blue nevi with degenerative stromal changes). Am. J. Dermatopathol. 2008; 30; 1-5.
64. Michal M, Baumruk L, Skalova A. Myxoid change within cellular blue naevi: a diagnostic pitfall. Histopathology 1992; 20; 527-530.
65. Michal M, Kerekes Z, Kinkor Z, Ondrias F, Pizinger K. Desmoplastic cellular blue nevi. Am. J. Dermatopathol. 1995; 17; 230-235.
66. Urso C, Tinacci G. Angiomatoid cellular blue nevus: a variant of blue nevus with an angioma-like appearance. J. Cutan. Pathol. 2005; 32; 385-387.
67. Busam KJ, Woodruff JM, Erlandson RA, Brady MS. Large plaque-type blue nevus with subcutaneous cellular nodules. Am. J. Surg. Pathol. 2000; 24; 92-99.
68. Murali R, McCarthy SW, Scolyer RA. Blue nevi and related lesions: a review highlighting atypical and newly described variants, distinguishing features and diagnostic pitfalls. Adv. Anat. Pathol. 2009; 16; 365-382.
69. Pittman JL, Fisher BK. Plaque-type blue nevus. Arch. Dermatol. 1976; 112; 1127-1128.
70. Wood WS, Tron VA. Analysis of HMB-45 immunoreactivity in common and cellular blue nevi. J. Cutan. Pathol. 1991; 18; 261-263.
71. Smith K, Germain M, Williams J, Skelton H. CD34-positive cellular blue nevi. J. Cutan. Pathol. 2001; 28; 145-150.
72. Aloi F, Pich A, Pippione M. Malignant cellular blue nevus: a clinicopathological study of 6 cases. Dermatology 1996; 192; 36-40.
73. Granter SR, McKee PH, Calonje E, Mihm MC Jr, Busam K. Melanoma associated with blue nevus and melanoma mimicking cellular blue nevus: a clinicopathologic study of 10 cases on the spectrum of so-called 'malignant blue nevus'. Am. J. Surg. Pathol. 2001; 25; 316-323.
74. Martin RC, Murali R, Scolyer RA, Fitzgerald P, Colman MH, Thompson JF. So-called 'malignant blue nevus': a clinicopathologic study of 23 patients. Cancer 2009; 115; 2949-2955.
75. Tran TA, Carlson JA, Basaca PC, Mihm MC. Cellular blue nevus with atypia (atypical cellular blue nevus): a clinicopathologic study of nine cases. J. Cutan. Pathol. 1998; 25; 252-258.
76. Barnhill RL, Argenyi Z, Berwick M et al. Atypical cellular blue nevi (cellular blue nevi with atypical features): lack of consensus for diagnosis and distinction from cellular blue nevi and malignant melanoma ('malignant blue nevus'). Am. J. Surg. Pathol. 2008; 32; 36-44.
77. Gammon B, Beilfuss B, Guitart J, Busam KJ, Gerami P. Fluorescence in situ hybridization for distinguishing cellular blue nevi from blue nevus-like melanoma. J. Cutan. Pathol. 2011; 38; 335-341.
78. Busam KJ. Metastatic melanoma to the skin simulating blue nevus. Am. J. Surg. Pathol. 1999; 23; 276-282.
79. Plaza JA, Torres-Cabala C, Evans H, Diwan HA, Suster S, Prieto VG. Cutaneous metastases of malignant melanoma: a clinicopathologic study of 192 cases with emphasis on the morphologic spectrum. Am. J. Dermatopathol. 2010; 32; 129-136.
80. Hantschke M, Mentzel T, Rutten A et al. Cutaneous clear cell sarcoma: a clinicopathologic, immunohistochemical, and molecular analysis of 12 cases emphasizing its distinction from dermal melanoma. Am. J. Surg. Pathol. 2010; 34; 216-222.